Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bjarnason, Ingvar Iain
MetadataShow full item record
CitationClin. Gastroenterol. Hepatol. 2007, 5(9):1040-5
AbstractBACKGROUND & AIMS: Nonsteroidal anti-inflammatory drug (NSAID) gastropathy is sufficiently important as to warrant co-administration of misoprostol or proton pump inhibitors or a switch to selective cyclooxygenase (COX)-2 inhibitors. However, the serious ulcer outcome studies suggested that 40% of the clinically significant gastrointestinal bleeding originated more distally, presumably from NSAID enteropathy. We used capsule enteroscopy to study small-bowel damage in patients on long-term NSAIDs and COX-2-selective agents. METHODS: Sixty healthy volunteers acted as controls. One hundred twenty and 40 patients on long-term NSAIDs and COX-2 selective agents, respectively, underwent a capsule enteroscopy study. Small-bowel damage was categorized and quantitated. RESULTS: Sixty-two percent of patients on conventional NSAIDs were abnormal, which differed significantly (P < .001) from controls. The main pathology related to reddened folds (13%), denuded areas (39%), and mucosal breaks (29%). Two percent had diaphragm-like strictures and 3% had bleeding without an identifiable lesion. The damage, seen in 50% of patients on selective COX-2 inhibitors (reddened folds, 8%; denuded areas, 18%; and mucosal breaks, 22%), did not differ significantly (P > .5) from that seen with NSAIDs. CONCLUSIONS: Long-term NSAIDs and COX-2-selective agents cause comparable small-bowel damage. This suggests an important role for COX-2 in the maintenance of small-bowel integrity. The results have implications for strategies that aim to minimize the gastrointestinal damage in patients requiring anti-inflammatory analgesics.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.
- Authors: Maiden L
- Issue date: 2009
- A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
- Authors: Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I
- Issue date: 2005 May
- Visible small-intestinal mucosal injury in chronic NSAID users.
- Authors: Graham DY, Opekun AR, Willingham FF, Qureshi WA
- Issue date: 2005 Jan
- Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAID) use as assessed by capsule endoscopy.
- Authors: Caunedo-Alvarez A, Gómez-Rodríguez BJ, Romero-Vázquez J, Argüelles-Arias F, Romero-Castro R, García-Montes JM, Pellicer-Bautista FJ, Herrerías-Gutiérrez JM
- Issue date: 2010 Feb
- Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
- Authors: Fujimori S, Seo T, Gudis K, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C
- Issue date: 2009 Jun